Rigel to Present at BIO CEO & Investor ... ( SOUTH SAN FRANCISCO Calif. Feb. 6...)

Rigel to Present at BIO CEO & Investor Conference

Date:2/6/2008

SOUTH SAN FRANCISCO, Calif., Feb. 6 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, the company's chairman and chief executive officer, is scheduled to present a company overview at the BIO CEO & Investor Conference 2008 in New York on Monday, February 11 at 11:45 a.m. EST.

To access the live audio webcast or the subsequent archived recording, log on to http://www.rigel.com. Please connect to Rigel's website several minutes prior to the start of the live webcast to ensure adequate time for any software download that may be necessary.

About Rigel (http://www.rigel.com)

Rigel is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory/autoimmune diseases and cancer, as well as viral and metabolic diseases. Our goal is to file one new investigational new drug (IND) application in a significant indication each year. Rigel has achieved this goal every year since 2002. Our pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. Rigel has product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia and asthma, as well as in cancer.

Contact: Ryan Maynard

Phone: 650.624.1284

Email: invrel@rigel.com

SOURCE Rigel Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:5/24/2013)... May 24, 2013 This market ... on kinase profiling carried out in May 2013. ... the breakdown of the responses for each question, ... (2015). It also highlights some interesting differences, particularly ... Two bottom-up models were developed to estimate the ...

(Date:5/24/2013)... 24, 2013 Vestiage, Inc. (stock ... focused on science-based research and development, sales and ... and nutraceuticals, announced today that it is awarding ... the sale of Reluma Skin Illuminating Facial Care. ... application by sending an email to info(at)vestiageinc(dot)com and ...

(Date:5/23/2013)... baby stopped breathing, his collapsed bronchus blocking the crucial ... Gionfriddo watched helplessly, just praying that somehow the dire ... he had a good chance of not leaving the ... son, Kaiba. "At that point, we were desperate. Anything ... with it." , They found hope at the University ...

(Date:5/23/2013)... Can economic incentives such as gift cards, ... the public to increase their donations of blood? , ... Business School Assistant Professor Mario Macis says the ... body of recent research that supports their argument, the ... of Science that the World Health Organization and national ...

Breaking Biology Technology:Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 2 Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 3 Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com 4 Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 2 Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 3 Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 4 Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 5 Baby's life saved with groundbreaking 3-D printed device that restored his breathing 2 Baby's life saved with groundbreaking 3-D printed device that restored his breathing 3 Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 2 Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science 3

[0] Kinase Market Profiling - In House & Outsourced Trends 2015 Forecast in New Research Report at ReportsnReports.com [0] Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA [0] Baby's life saved with groundbreaking 3-D printed device that restored his breathing [0] Offering Economic Incentives to Attract Blood Donations Should Be Encouraged, Research Team writes in Science

... China, Feb. 7 /Xinhua-PRNewswire-FirstCall/ -- Tianyin,Pharmaceutical, Inc., (OTC ... traditional Chinese medicine (TCM) based in Chengdu,China, today ... the Board of,Directors, will host a conference call ... results., The conference call will take place ...

... 7 Dilon Technologies, makers of,a gamma imaging system ... Moussa to the position of President and Chief Executive,Officer., ... the medical device industry,having held a number of senior ... a health care corporation he ran as,CEO for a ...

... 7 MedImmune today announced,that it has strengthened ... affairs with three key promotions and has also ... Kiener, D. Phil. has been appointed,to executive vice ... organization development, HR; and Eileen Valenta to vice ...

Cached Biology Technology:Tianyin Pharmaceutical, Inc. to Host 2008 Second Quarter Earnings Conference Call on Thursday, February 14, 2008 at 4:15 p.m. EST 2 Newly Appointed Dilon Technologies President & CEO Robert G. Moussa Sees BSGI as ' ... Major Weapon in the Battle Against Cancer' 2 MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio 2 MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio 3 MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio 4

Tianyin Pharmaceutical, Inc. to Host 2008 Second Quarter Earnings Conference Call on Thursday, February 14, 2008 at 4:15 p.m. EST Newly Appointed Dilon Technologies President & CEO Robert G. Moussa Sees BSGI as ' ... Major Weapon in the Battle Against Cancer'MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio

(Date:5/23/2013)... said to be the world,s most popular fruit, can ... research with purple GM varieties. , "Working with ... by the addition of a specific compound, allows us ... said Professor Cathie Martin from the John Innes Centre. ... with better flavour, health and shelf life characteristics because ...

(Date:5/23/2013)... By discovering the new mechanism by which estrogen suppresses ... revealed a potential new approach toward treating certain liver ... and colleagues believe they are changing long-held views in ... issue of the journal Science Signaling . , ... years has been that only receptors located in the ...

(Date:5/23/2013)... (May 23, 2013) A new report from the ... helping pupils engage in at least 60 minutes of ... , No more than half of American youth meet ... vigorous or moderate intensity physical activity daily, according to ... children are in school for nearly half of their ...

Breaking Biology News(10 mins):The world's favorite fruit only better-tasting and longer-lasting 2 UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2 Schools should provide students with daily physical activity, IOM recommends 2

[0] The world's favorite fruit only better-tasting and longer-lasting [0] UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis [0] Schools should provide students with daily physical activity, IOM recommends

... at The University of Texas at Austin have devised a ... help people with Parkinson,s disease. The worms are able ... The researchers have received federal funding that could increase that ... is based on the difficulty that these "parkinsonian" C. ...

... play a far greater role in the fate of African elephants ... on these largest terrestrial animals, according to a new University of ... week. In some of the best-documented cases to date, the ... one of the last strongholds of forest elephants in the Democratic ...

... tundra are growing faster, suggesting that at least some forests ... new study. While forests elsewhere are thinning from wildfires, ... white spruce trees in the far north of Alaska have ... 1950, the study has found. The health of forests globally ...

Cached Biology News:Parkinsonian worms may hold the key to identifying drugs for Parkinson's disease 2 Parkinsonian worms may hold the key to identifying drugs for Parkinson's disease 3 More than 50 percent decline in elephants in eastern Congo due to human conflict: UBC research 2 Trees on tundra's border are growing faster in a hotter climate 2 Trees on tundra's border are growing faster in a hotter climate 3 Trees on tundra's border are growing faster in a hotter climate 4

Parkinsonian worms may hold the key to identifying drugs for Parkinson's disease More than 50 percent decline in elephants in eastern Congo due to human conflict: UBC research Trees on tundra's border are growing faster in a hotter climate

... recombinant protein that has been shown to help ... of cDNA by reverse transcription, in vitro RNA ... Safe Inhibitor tightly binds RNases in a 1:1 ... RNases such as RNase A, RNase B, RNase ...

... The BIOLASE Core Kit contains ... perform polymerase assays on a ... In addition to dNTPs, the ... our widely used BIOLASE DNA ...

Chicken Aortic Smooth Muscle Cells (CAOSMC) (>500,000 cells)...

... The National Collection of Pathogenic ... authenticated human pathogenic viruses in ... is able to supply the ... from them, to the scientific ...

Biology Products:

GeneChoice RNA Safe Recombinant Ribonuclease Inhibitor from GeneChoice, Inc.Biolase Core Kit from Bioline CAOSMC (C354-05) from European Collection of Cell Cultures (ECACC)The National Collection of Pathogenic Viruses (NCPV) from European Collection of Cell Cultures (ECACC)